scispace - formally typeset
H

Harry A. Quigley

Researcher at Johns Hopkins University

Publications -  506
Citations -  72465

Harry A. Quigley is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Glaucoma & Intraocular pressure. The author has an hindex of 115, co-authored 492 publications receiving 65186 citations. Previous affiliations of Harry A. Quigley include University of Miami & Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

Intraobserver and interobserver agreement in measurement of optic disc characteristics.

TL;DR: Both intraobserver and interobserver agreement for horizontal and vertical cup:disc ratios and width of the narrowest remaining neuroretinal rim on stereo, color, fundus photographs were best for glaucoma patients followed by ocular hypertensives and controls.
Journal ArticleDOI

Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.

TL;DR: Assessment of patient adherence and behaviors with topical once-daily therapy for glaucoma found nearly 45% of patients using an electronic monitoring device who knew they were being monitored and were provided free medication used their drops less than 75% of the time.
Journal ArticleDOI

Adherence and Persistence with Glaucoma Therapy

TL;DR: Findings from The Glaucoma Adherence and Persistency Study are reviewed, which identified behaviors associated with poor adherence and methods to assess adherence and persistence and the patient behaviors that pose challenges to proper treatment.
Journal ArticleDOI

Doctor–Patient Communication, Health-Related Beliefs, and Adherence in Glaucoma: Results from the Glaucoma Adherence and Persistency Study

TL;DR: These findings indicate that doctor-patient communications and health-related beliefs of patients contribute to patient adherence and suggest that educational efforts in the office may improve patient adherence to medical therapies.
Journal ArticleDOI

Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).

TL;DR: It is confirmed that adherence to treatment with glaucoma medications is poor, similar to adherence in patients with other chronic diseases, and MPR is a robust measure of adherence over time that reflects the resumption of medication after a gap in adherence.